Origin Therapeutics Holdings (DB:U8B) - Stock Price, News & Analysis

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

U8B Stock Overview

Origin Therapeutics Holdings Inc., an investment issuer, primarily focuses on investments in the psychedelic industry in Canada.

About the company

U8B fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (€1M)

Shares are highly illiquid

Origin Therapeutics Holdings Inc. Competitors

Nabag

HMSE:NAB

€2.0m

Trade & Value

HMSE:TAV

€409.5k

Q-Soft Verwaltungs

BST:QS6A

€2.5m

CAMERIT

DB:RTML

€1.8m

Price History & Performance

Summary of all time highs, changes and price drops for Origin Therapeutics Holdings
Historical stock prices
Current Share Price	CA$0.016
52 Week High	CA$0.024
52 Week Low	CA$0.013
Beta	0
11 Month Change	0%
3 Month Change	-33.33%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.23%

Recent updates

Shareholder Returns

	U8B	DE Capital Markets	DE Market
7D	0%	1.6%	4.5%
1Y	n/a	29.0%	13.4%

Return vs Industry: Insufficient data to determine how U8B performed against the German Capital Markets industry.

Return vs Market: Insufficient data to determine how U8B performed against the German Market.

Price Volatility

Is U8B's price volatile compared to industry and market?
U8B volatility
U8B Average Weekly Movement	n/a
Capital Markets Industry Average Movement	4.8%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: U8B's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine U8B's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	Michael Galego	www.originpsychedelics.com

Origin Therapeutics Holdings Inc., an investment issuer, primarily focuses on investments in the psychedelic industry in Canada. It plans to invests in the research, design, development, testing, production, distribution, and sale of psychedelics and related activities. The company was formerly known as 1278700 B.C.

Origin Therapeutics Holdings Inc. Fundamentals Summary

How do Origin Therapeutics Holdings's earnings and revenue compare to its market cap?
U8B fundamental statistics
Market cap	€979.25k
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is U8B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
U8B income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did U8B perform over the long term?

See historical performance and comparison

Origin Therapeutics Holdings DB:U8B Stock Report